ATYR
Price:
$0.4404
Market Cap:
$43.18M
aTyr Pharma, Inc., a biopharmaceutical firm established in San Diego, California, in 2005, is dedicated to the discovery and advancement of therapeutic solutions. Operating within the United States, the company's research focuses on pioneering novel immunological pathways to address various medical conditions. Its primary investigational drug, efzofitimod, functions as a selective modulator of NRP2. This compound is currently undergoing a Phase III clinical trial for pulmonary sarcoidosis. Additionally, efzofitimod is being evaluated in a Phase 1b/2a clinical study for the treatment of other interstitial lung diseases (ILDs), including conditions such as chronic hypersensitivity pneumonitis ...[Read more]
Industry
Biotechnology
IPO Date
2015-05-07
Stock Exchange
NASDAQ
Ticker
ATYR
According to aTyr Pharma, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.60. This represents a change of -75.19% compared to the average of -2.42 of the last 4 quarters.
The mean historical PE Ratio of aTyr Pharma, Inc. over the last ten years is -1.05. The current -0.60 PE Ratio has changed 5.60% with respect to the historical average. Over the past ten years (40 quarters), ATYR's PE Ratio was at its highest in in the March 2020 quarter at 1.70. The PE Ratio was at its lowest in in the June 2025 quarter at -5.85.
Average
-1.05
Median
-0.98
Minimum
-4.20
Maximum
-0.05
Discovering the peaks and valleys of aTyr Pharma, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 297.14%
Maximum Annual PE Ratio = -0.05
Minimum Annual Increase = -76.60%
Minimum Annual PE Ratio = -4.20
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -0.98 | -76.60% |
| 2024 | -4.20 | 128.14% |
| 2023 | -1.84 | 69.72% |
| 2022 | -1.08 | 10.93% |
| 2021 | -0.98 | 0.08% |
| 2020 | -0.98 | 297.14% |
| 2019 | -0.25 | 129.32% |
| 2018 | -0.11 | 62.18% |
| 2017 | -0.07 | 30.75% |
| 2016 | -0.05 | 23.98% |
The current PE Ratio of aTyr Pharma, Inc. (ATYR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-2.34
5-year avg
-1.82
10-year avg
-1.05
aTyr Pharma, Inc.’s PE Ratio is greater than ALX Oncology Holdings Inc. (-0.97), greater than CAMP4 Therapeutics Corporation (-2.81), less than Quince Therapeutics, Inc. (-0.14), less than Metagenomi, Inc. Common Stock (-0.53), greater than Repare Therapeutics Inc. (-1.58), greater than Unicycive Therapeutics, Inc. (-43.39), greater than Relmada Therapeutics, Inc. (-9.78), greater than Acrivon Therapeutics, Inc. Common Stock (-0.74), greater than MindWalk Holdings Corp. (-8.33), greater than Precision BioSciences, Inc. (-1.76),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.97 | $212.61M | |
| -2.81 | $89.00M | |
| -0.14 | $5.20M | |
| -0.53 | $45.18M | |
| -1.58 | $114.24M | |
| -43.39 | $155.81M | |
| -9.78 | $487.67M | |
| -0.74 | $46.70M | |
| -8.33 | $72.87M | |
| -1.76 | $78.25M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like aTyr Pharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like aTyr Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is aTyr Pharma, Inc.'s PE Ratio?
How is the PE Ratio calculated for aTyr Pharma, Inc. (ATYR)?
What is the highest PE Ratio for aTyr Pharma, Inc. (ATYR)?
What is the 3-year average PE Ratio for aTyr Pharma, Inc. (ATYR)?
What is the 5-year average PE Ratio for aTyr Pharma, Inc. (ATYR)?
How does the current PE Ratio for aTyr Pharma, Inc. (ATYR) compare to its historical average?